Salem Partners, LLC - Investment Banking and Wealth Management
  • Home
  • About
  • Investment Banking
    • Valuation Services
    • Media & Entertainment
    • Healthcare & Life Sciences
    • Real Estate
    • Transactions
  • Wealth Management
    • Portfolio Log In
  • Real Estate Development
  • Professionals
  • News
  • Contact

SALEM PARTNERS ANNOUNCES SUCCESSFUL CLOSING ON BEHALF OF GEYSER HOLDINGS, LLC

12/30/2020

 
Picture
Salem Partners, LLC (“Salem”) is pleased to announce a successful closing on behalf of its client, Geyser Holdings, LLC and its CEO, Russell Geyser (“Geyser”). Geyser hired Salem to identify and raise the required joint-venture equity capital with the objective to acquire an institutional class, creative office asset called Hollywood 959, located in the heart of the Hollywood Media District in Los Angeles, CA.

​Hollywood 959 is a recently developed, 250,000 SF class A, creative office campus developed by JH Snyder Co. Located next door to Sunset Las Palmas Studios, Hollywood 959 is... (read more)

OncoNano Announces Presentations at the 2019 SITC Annual Meeting

11/5/2019

 
Picture
 OncoNano Medicine, Inc., a biotechnology company developing ultra pH-sensitive micelles for the detection, staging and treatment of cancer, today announced two poster presentations – including a late-breaking abstract – for the Society for the Immunotherapy of Cancer (SITC) Annual Meeting to be held in National Harbor, Maryland, November 6-10. OncoNano’s core technology is a library of tunable, ultra pH-sensitive micelles that exist intact under baseline physiological pH conditions but dissociate to release their payload under different, predesignated pH levels... (read more)


OncoNano Awarded $15.4 Million Grant from Cancer Prevention and Research Institute of Texas

8/27/2019

 
Picture
OncoNano Medicine, Inc. today announced that it has been awarded $15.4 million from the Cancer Prevention and Research Institute of Texas (CPRIT) to advance ONM-500, one of OncoNano’s innovative oncology product candidates. In ONM-500, OncoNano leverages its proprietary pH-sensitive micelle technology to deliver antigens while activating innate immunity for the treatment of cancers caused by the human papilloma virus (HPV). This grant award adds to an initial $6 million grant that the company received from CPRIT in 2014 for advancement of the company’s ONM-100, where OncoNano’s micelle technology is being used to intraoperatively image tumors during surgical resection, currently in Phase 2 clinical trials... (read more)

SALEM PARTNERS ANNOUNCES SUCCESSFUL COMPLETION AND PLACEMENT OF $35 MILLION SENIOR LOAN

8/26/2019

 
Picture
Salem Partners, LLC (“Salem Partners”) is pleased to announce the successful completion of a $35 million senior loan for its client, Urban Mining Company (“UMC”) and its investors and affiliates. UMC presented Salem Partners with the challenge to structure a credit product that would provide enough proceeds to refinance its existing real estate debt, finish its mission critical manufacturing facility in the Austin / San Marcos region of Texas and capitalize all transaction and interest costs (a proceeds level which was unavailable by typical bank lenders) all within a tight time frame... (read more)

SALEM PARTNERS ANNOUNCES RECENT MULTIFAMILY COMMUNITY EQUITY FINANCING​

7/15/2019

 
Picture
Salem Partners is pleased to announce yet another recent multifamily community equity financing as part of the success of an ongoing joint-venture in the real estate / multifamily sector for its client, Grand Peaks Properties, Inc. (“GPP”). The joint-venture is between GPP and a global family office with the objective to aggregate $1 billion of institutional quality multifamily assets (the “Program”).

The most recent equity financing closed on July 15th, 2019 where $23 million of equity capital was allocated to a ground-up construction project in Denver, CO. Prior to this, $25 million was allocated to value-add / renovation project in the Miami, FL market. Since the initial closing in 2017, the Program has acquired / developed six (6) properties in their key markets (listed below) totaling nearly $500 million in gross value across thousands of apartment units... (read more)

OncoNano Announces Completion of Phase 1a Study and Expands into Phase 1b for Intraoperative Imaging Agent to Detect Tumors and Metastatic Lymph Nodes That Often Go Undetected During Surgery

12/5/2018

 
Picture
OncoNano Medicine, Inc. today announced the completion of its Phase 1a clinical trial and expansion into Phase 1b to evaluate ONM-100, the intravenously administered imaging agent to detect tumors and metastatic lymph nodes in solid cancers during surgery. The results of Phase 1a will be included in a poster presentation at the San Antonio Breast Cancer Symposium being held on December 4-8, 2018... (read more)

AsclepiX Therapeutics Raises $5M in New Funding

11/13/2018

 
Picture
​AsclepiX Therapeutics, Inc., a biopharmaceutical company focused on developing vital new therapies based on a novel peptide platform, today announced that it has raised $5 million in Convertible Note funding, led by Barer & Son Capital with additional funds from Rapha Capital Management, Salem Partners, TEDCO, and Piedmont Capital Partners. In concert with the funding, AsclepiX expanded its board to add Josh Barer, Kevin Slawin, MD, and Sapna Srivastava, PhD, to the founding members Aleksander Popel, PhD and Jordan J. Green, PhD and CEO Wendy Perrow, MBA... (read more)

U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne

9/17/2018

 
Picture
Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its lead product, Sebacia Microparticles. This significant achievement is a milestone in the treatment of acne and follows the company’s completion of its pivotal study, which clearly demonstrated clinical efficacy and safety of Sebacia Microparticles, and its 510(k) submission to the FDA in June 2018... (read more)

Synteract Acquires Dermatology CRO Cu-Tech, LLC

7/11/2018

 
Picture
Synteract has snapped up the specialty contract researcher Cu-Tech, with plans to establish a dedicated center for the development of dermatology products and make the midsized, global CRO into a destination for skin-care clinical trials.
​
The Mountain Lakes, New Jersey-based Cu-Tech has managed more than 130 dermatology trials over the past two decades, covering a variety of indications... (read more)

SALEM PARTNERS ANNOUNCES SUCCESSFUL COMPLETION AND PLACEMENT OF $54 MILLION REVOLVING CREDIT FACILITY

6/13/2018

 
Picture
Salem Partners, LLC is pleased to announce the successful completion and placement of a $54 million revolving credit facility for its client, Eisenhower Property Group (“EPG”). Salem Partners advised EPG on an exclusive basis and selected a credit hedge fund to provide the financing. First closing of the facility occurred on June 13th, 2018.

Jeff Barcy, Managing Director of Salem Partners’ real estate investment banking group, and Parker Bennett, Director of real estate investment banking, led negotiations and... (read more)

OncoNano Announces $11.7 Million Series A Financing to Support Development of pH-activated Compound Platform for Disease Detection and Treatment

5/17/2018

 
Picture
SOUTHLAKE, TX - OncoNano Medicine, Inc. today announced the closing of a $11.7 million Series A financing. The transaction was arranged by Salem Partners, who also participated as a principal investor. The Series A funding supplements a $6 million grant previously received from the Cancer Prevention and Research Institute of Texas (CPRIT). The funding will be used to support the company’s continued clinical development of a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease indications such as cancer. The company is also pleased to announce the appointment of five established industry leaders to its Board of Directors... (read more)

SALEM PARTNERS ANNOUNCES SUCCESSFUL COMPLETION OF $35 MILLION SENIOR DEBT PLACEMENT

4/19/2018

 
Picture
LOS ANGELES, CA - Salem Partners, LLC is pleased to announce the successful completion of a $35 million senior debt placement for its client, a real estate partnership between, BTI Partners & Westport Capital Partners. This partnership acquired, developed and opened the “The Grove Resort & Spa” in Orlando, Florida, which is a multi-phased condo / hotel / resort near Walt Disney World, Orlando. The debt transaction closed in March of 2018, with Salem Partners acting as the.​.. (read more)

SALEM PARTNERS ANNOUNCES SUCCESSFUL COMPLETION OF $40 MILLION CONVERTIBLE PREFERRED EQUITY PLACEMENT

1/23/2018

 
Picture
LOS ANGELES, CA - Salem Partners, LLC is pleased to announce the successful completion of a $40 million convertible preferred equity placement for its client, Four Springs Capital Trust (“FSCT” or “Four Springs”) with Guggenheim Investments (“Guggenheim”).  The transaction closed on January 23th, 2018, with Salem Partners acting as the financial advisor and investment bank to FSCT.  Jeff Barcy, Managing Director of Salem Partners’ real estate investment banking group, and Parker Bennett, Director of real estate investment banking, led negotiations... (read more)

Gravitas Ventures Sells Majority Stake To ProSieben’s Red Arrow International

11/8/2017

 
Picture
LOS ANGELES, CA - Indie distributor Gravitas Ventures has been snapped up by Red Arrow International, an arm of Germany’s ProSiebenSat.1. As part of the majority stake transaction announced today, all Gravitas Ventures employees will be retained and... (read more)

Sebacia Announces $36 Million Equity And Debt Financing To Advance Breakthrough In-Office Procedure For Acne

7/25/2017

 
Picture
DULUTH, GA - Sebacia, Inc., a privately held, clinical and commercial stage dermatology and aesthetics company, today announced that the company has completed a $20 million Series D financing led by existing investors Versant Ventures, Domain Associates, Accuitive Medical Ventures and Partners Healthcare Innovation Fund... (read more)

SALEM PARTNERS SELLS HONOLULU FLAGSHIP WALGREENS FOR $42.25 MILLION

7/19/2017

 
Picture
HONOLULU, HI - ​Salem Partners, through one of its affiliated entities, has sold a Walgreens flagship store located at 1500 Kapiolani Boulevard in Honolulu for $42.25 million, one of the highest sales prices for a store in Walgreens’ history... (read more) 

Salem announces successful completion of programmatic joint-venture in real estate / Multifamily sector

2/28/2017

 
Picture
LOS ANGELES, CA -- ​Salem Partners is pleased to announce the successful completion of a programmatic joint-venture in the real estate / multifamily sector for its client, Grand Peaks Properties, Inc. (“GPP”). The joint-venture is between GPP and a global family office with the objective to aggregate $1 billion of multifamily assets.  GPP is a vertically-integrated, national operator... (read more)

Salem Partners and Mandarin Oriental Announce Plans to Open a Luxury Hotel and Residences in Honolulu

2/6/2017

 
Picture
LOS ANGELES, CA - Salem Partners, a leading Los Angeles-based investment bank and wealth management firm, has partnered with luxury hotel group Mandarin Oriental with intention to open a hotel and branded residences currently under development in Honolulu on the Hawaiian island of Oahu. Targeted to open in early 2020, the Mana’olana Place development provides... (read more)

Femasys Announces $40 Million in Series C Financing to Complete Development of FemBloc™

12/15/2016

 
Picture
ATLANTA, GA - Femasys Inc., a developer of innovative medical devices for the women's healthcare market, today announced that it has closed $40 million in Series C financing.  The transaction was arranged by Salem Partners, a Los Angeles-based investment bank which also participated as a principal investor.  The Series C syndicate included multiple... (read more)

ESCO Technologies acquires Mayday and its affiliate, Hi-Tech 

11/14/2016

 
Picture
ST. LOUIS, MO - ESCO Technologies Inc. (NYSE: ESE) announced that it has acquired Mayday Manufacturing Co. (Mayday) and its affiliate, Hi-Tech Metals, Inc. (Hi-Tech). Mayday and Hi-Tech (collectively, the "Business") are industry leading aerospace suppliers operating together in a state-of-the-art, expandable 130,000 square foot facility in Denton, Texas... (read more)

Honolulu City Council Approves Salem Partners’ Plan for $700 Million, 36-Story MixeD-use tower

10/11/2016

 
Picture
​LOS ANGELES, CA - The Honolulu City Council has approved a $700 million, 36-story mixed-use tower across from the Convention Center to be developed by Los Angeles-based Salem Partners. Located at the intersection of Kapiolani Boulevard and Atkinson Drive, Mana`olana Place is the first approved project in the city’s newly adopted Ala Moana transit-oriented district and is expected to be a catalyst for further investment in the area. The iconic tower’s 505,000 square feet will house a 125-room ultra-luxury hotel.... (read more)

Salem partners successfully closes healthcare real estate Joint-Venture

7/27/2016

 
Picture
LOS ANGELES, CA - Salem Partners is pleased to announce the successful completion of a large programmatic joint-venture in the real estate / medical office sector for its client, Everest Medical Core Properties (“Everest MCP”). The joint-venture is between Everest MCP and a major, U.S. based real estate private equity firm.... (read more).

Architects Hawaii Garners Top Design Award in National Competition

12/15/2015

 
Picture
HONOLULU, HI - ​Walgreens’ Hawaii flagship store in Honolulu won this year’s highest level of recognition in the retail store design category of the International Council of Shopping Centers’ awards competition for U.S. design and development... (read more)

Femasys Announces Todd Creech as Chief Financial Officer

12/14/2015

 
Picture
ATLANTA, GA - December 14, 2015 --- Femasys Inc., a developer of innovative medical devices for the women’s healthcare market today announced the appointment of Todd A. Creech as Chief Financial Officer. Mr. Creech will serve as Femasys’ principal financial and... (read more)

WALGREENS SELLS ITS FLAGSHIP HAWAII STORE AND ADJACENT HEALD COLLEGE BUILDING FOR $73.5M

11/30/2015

 
Picture
HONOLULU, HI - Walgreens has sold its flagship Hawaii store across from Ala Moana Center in Honolulu, along with the adjacent Heald College Building on Kapiolani Boulevard, to Los Angeles-based investment bank and wealth management firm Salem Partners for a total of $73.5 million...(read more)

<<Previous

    News

    All
    Aerospace & Defense
    Healthcare & Life Sciences
    Investment Banking
    Media & Entertainment
    Real Estate
    Wealth Management

    Archives

    December 2020
    November 2019
    August 2019
    July 2019
    December 2018
    November 2018
    September 2018
    July 2018
    June 2018
    May 2018
    April 2018
    January 2018
    November 2017
    July 2017
    February 2017
    December 2016
    November 2016
    October 2016
    July 2016
    December 2015
    November 2015
    October 2015
    July 2015
    June 2015
    May 2015
    April 2015
    December 2014
    October 2014
    August 2014
    July 2014
    June 2014
    April 2014
    March 2014
    November 2013
    October 2013
    February 2013
    December 2012
    October 2012
    February 2012
    January 2012
    December 2011
    September 2011
    August 2011
    June 2011
    January 2010
    December 2009
    November 2009
    August 2009
    June 2009
    February 2009
    September 2008
    August 2008
    July 2008
    June 2008
    May 2008
    April 2008
    February 2008
    December 2007
    July 2007
    May 2007
    February 2007
    January 2007
    December 2006
    November 2006
    October 2006

    RSS Feed

© 2016 by Salem Partners LLC - All Rights Reserved. Member FINRA/SIPC.
11111 Santa Monica Blvd. Suite 2250, Los Angeles, CA 90025